2014 is Tony Rodriguez’s 22nd year in practice. His experience includes numerous complex and high-profile representations of corporations, board committees and individual directors, and corporate officers in class action and derivative litigation, SEC matters, and internal investigations. He has represented clients in a variety of industries, including mortgage lending; energy; semiconductor; networking; broadband; e-commerce; pharmaceutical; broadcasting hardware; software; and chemicals. He has extensive experience in representing outside directors individually, as well as board committees composed of outside directors, and has spent years following developments in the law regarding outside directors’ “due diligence” defense to actions under the Securities Act of 1933.

He also has extensive experience defending companies in antitrust and unfair competition claims, ranging from allegations of horizontal market division to allegations of price fixing. These clients have included consumer beverage, LCD, and sports and concert ticket sales companies. Mr. Rodriguez’s experience also includes the defense of a leading prescription drug wholesaler in actions brought by several states’ Medicaid or other agencies, with each action including claims in the tens or hundreds of millions of dollars in alleged damages and penalties. Mr. Rodriguez also has represented major companies in litigation arising from Internet trademark use, hard drive failures, and the carrying of ISP-bound traffic. Mr. Rodriguez's peers rate him "AV Preeminent" in the Martindale-Hubbell Peer Review Ratings. He co-chairs the Derivative Suits Subcommittee of the ABA’s Securities Litigation Committee.